Hiring?
Logo

Treating Osteoporosis

location_on

West, USA

Short Summary

We improve skeletal health to extend lifespan and increase quality of life

Overview

Target
US$1,000,000
Minimum
US$100
Investment Raised
US$50,000
Previous Rounds N/A
Stage MVP/Finished Product
Investor Role Silent

Highlights

  • OsNovum founders own the patent to this technology
  • FDA-cleared for maxillofacial use, streamlining track to clearance in body
  • Disruptive new technology for the $73B osteoporosis treatment industry
  • Parent company, a bone regenerative company, provides building and staff
  • Profits generated by our regenerative tech--accelerated by OsNovum clinics
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Pro
32% raised

CellX Technologies

location_on North East, USA

Cell X Technologies, Inc. is a spin-out of the Cleveland Clinic by Dr George Muschler. “Cell X”, is an automated robotic cell processing platform, designed and engineered in collaboration with Parker Hannifin Corporation.

US$ 2,500,000

Target

US$ 10,000

Min per Investor

Pro
0% raised

Thc/cbd Lab Equipment

location_on South East, USA

US$ 250,000

Target

US$ 250,000

Min per Investor

Global Pro
0% raised

Health and Wellness

location_on South East, USA

Bloomie Garden provides high performance corrective and preventative holistic skincare targeting skin issues and treatments for hair growth products. All containing potent ingredients with a nutritious plant-base that is derived from botanical juice

US$ 100,000

Target

US$ 70,000

Min per Investor

load one similar proposal